γδ T CELLS MEDIATE IMMUNOTHERAPY RESPONSE IN HLA CLASS I-DEFICIENT CANCERS

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2023年 / 13卷 / 03期
关键词：
D O I：
10.1158/2159-8290.CD-RW2023-012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
γδ T cells contribute to the efficacy of immunotherapy in the absence of antigen presentation. ©2023 American Association for Cancer Research.
引用
收藏
页码：528 / 528
页数：1
相关论文
共 50 条
  • [1] Immunotherapy of bladder cancer induces selection of HLA class I-deficient tumor cells
    Carretero, R.
    Cabrera, T.
    Rodriguez, A. I.
    Gil, H.
    Saenz-Lopez, P.
    Maleno, I.
    Aptsiauri, N.
    Cozar, J. M.
    Garrido, F.
    TISSUE ANTIGENS, 2011, 77 (05): : 395 - 395
  • [2] γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
    de Vries, Natasja L.
    van de Haar, Joris
    Veninga, Vivien
    Chalabi, Myriam
    Ijsselsteijn, Marieke E.
    van der Ploeg, Manon
    van den Bulk, Jitske
    Ruano, Dina
    van den Berg, Jose G.
    Haanen, John B.
    Zeverijn, Laurien J.
    Geurts, Birgit S.
    de Wit, Gijs F.
    Battaglia, Thomas W.
    Gelderblom, Hans
    Verheul, Henk M. W.
    Schumacher, Ton N.
    Wessels, Lodewyk F. A.
    Koning, Frits
    de Miranda, Noel F. C. C.
    Voest, Emile E.
    NATURE, 2023, 613 (7945) : 743 - 750
  • [3] γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
    Natasja L. de Vries
    Joris van de Haar
    Vivien Veninga
    Myriam Chalabi
    Marieke E. Ijsselsteijn
    Manon van der Ploeg
    Jitske van den Bulk
    Dina Ruano
    Jose G. van den Berg
    John B. Haanen
    Laurien J. Zeverijn
    Birgit S. Geurts
    Gijs F. de Wit
    Thomas W. Battaglia
    Hans Gelderblom
    Henk M. W. Verheul
    Ton N. Schumacher
    Lodewyk F. A. Wessels
    Frits Koning
    Noel F. C. C. de Miranda
    Emile E. Voest
    Nature, 2023, 613 : 743 - 750
  • [4] Immunotherapy of MHC class I-deficient tumors
    Reinis, Milan
    FUTURE ONCOLOGY, 2010, 6 (10) : 1577 - 1589
  • [5] Overcoming immunoevasion in MHC class I-deficient cancers
    Danelli, Luca
    NATURE CANCER, 2024, 5 (12) : 1788 - 1788
  • [6] Prospects for immunotherapy of MHC class I-deficient tumours
    Bubeník, J
    FOLIA BIOLOGICA, 2003, 49 (03) : 95 - 99
  • [7] γδ T cells mediate immunotherapy responses when cancers lack MHC class I
    Bordon, Yvonne
    NATURE REVIEWS IMMUNOLOGY, 2023, 23 (03) : 137 - 137
  • [8] γδ T cells mediate immunotherapy responses when cancers lack MHC class I
    Yvonne Bordon
    Nature Reviews Immunology, 2023, 23 : 137 - 137
  • [9] Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts
    Wu, MF
    Raulet, DH
    JOURNAL OF IMMUNOLOGY, 1997, 158 (04): : 1628 - 1633
  • [10] ISOLATION OF FUNCTIONAL MHC CLASS I-DEFICIENT ISLET CELLS
    OSORIO, RW
    ASCHER, NL
    JAENISCH, R
    NATUZZI, ES
    FREISE, CE
    ROBERTS, JP
    STOCK, PG
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 968 - 969
12345